Cargando…
Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice
SIMPLE SUMMARY: Immunotherapies have revolutionized the field of oncology and have been approved to treat cancer. Despite progress in immunotherapy, many challenges remain, including the identification (i) of predictive markers for treatment response or (ii) of beneficial T cell subsets involved in...
Autores principales: | Bruss, Christina, Kellner, Kerstin, Ortmann, Olaf, Seitz, Stephan, Brockhoff, Gero, Hutchinson, James A., Wege, Anja Kathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103756/ https://www.ncbi.nlm.nih.gov/pubmed/35565343 http://dx.doi.org/10.3390/cancers14092214 |
Ejemplares similares
-
Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
por: Bruss, Christina, et al.
Publicado: (2023) -
The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
por: Brockhoff, Gero, et al.
Publicado: (2017) -
CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM)
por: Wege, Anja Kathrin, et al.
Publicado: (2021) -
Multiparameter Flow Cytometry: Advances in High Resolution Analysis
por: O'Donnell, Erika A, et al.
Publicado: (2013) -
IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)
por: Wege, Anja K, et al.
Publicado: (2016)